850033-67-9 Usage
Uses
Used in Organic Synthesis:
2-N-Cbz-2-methylpropane-1,2-diamine-HCl is used as a building block or reagent in the field of organic synthesis. Its carboxybenzyl protective group allows for selective reactions and protection of the amine groups, facilitating the synthesis of more complex molecules.
Used in Chemical Reactions:
2-N-Cbz-2-methylpropane-1,2-diamine-HCl is employed in various chemical reactions, where its diamine functionality and carboxybenzyl protective group can be utilized to form new bonds and create different chemical entities. Its solubility in water makes it a versatile reagent for reactions in aqueous media.
Used in Pharmaceutical Industry:
2-N-Cbz-2-methylpropane-1,2-diamine-HCl is used as an intermediate in the synthesis of pharmaceutical compounds. Its unique structure and reactivity can be harnessed to develop new drugs or improve the synthesis of existing ones.
Used in Research and Development:
In the context of research and development, 2-N-Cbz-2-methylpropane-1,2-diamine-HCl is used as a model compound to study the properties and reactivity of diamines and their derivatives. This can lead to a better understanding of the underlying chemistry and the development of new synthetic strategies.
Check Digit Verification of cas no
The CAS Registry Mumber 850033-67-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,0,0,3 and 3 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 850033-67:
(8*8)+(7*5)+(6*0)+(5*0)+(4*3)+(3*3)+(2*6)+(1*7)=139
139 % 10 = 9
So 850033-67-9 is a valid CAS Registry Number.
850033-67-9Relevant academic research and scientific papers
N-HALOGENATED AMINO COMPOUNDS AND DERIVATIVES
-
Page/Page column 80, (2008/12/07)
The present invention relates to active bactericidal, antibacterial, anti-infective, antimicrobial, sporicidal, disinfectant, antifungal and antiviral compounds and compositions and to new uses of these compositions in therapy. This specification also describes methods of use for the new compounds and compositions. The specification further describes methods for preparing these compounds.
